You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Limiting allergic responses with B cells
B cells promote immune responses by producing antibodies; however, subsets of B cells secrete the anti-inflammatory cytokine interleukin-10 (IL-10) and have immunosuppressive properties. Kim et al. found that these B cells inhibited the activation of mast cells, immune cells that are critical regulators of allergic reactions. Indeed, mice lacking these special B cells had more severe symptoms of anaphylaxis. Mast cell inhibition required physical contact with the B cells, which stimulated the B cells to produce more IL-10. B cell–mediated inhibition of mast cells depended on IL-10, which inhibited tyrosine kinase signaling in mast cells. Thus, IL-10–producing B cells might provide a therapeutic target to treat allergic diseases.
Abstract
Subsets of B cells inhibit various immune responses through their production of the cytokine interleukin-10 (IL-10). We found that IL-10–producing CD5+ B cells suppressed the immunoglobulin E (IgE)– and antigen-mediated activation of mast cells in vitro as well as allergic responses in mice in an IL-10–dependent manner. Furthermore, the suppressive effect of these B cells on mast cells in vitro and in vivo depended on direct cell-to-cell contact through the costimulatory receptor CD40 on CD5+ B cells and the CD40 ligand on mast cells. This contact enhanced the production of IL-10 by the CD5+ B cells. Through activation of the Janus-activated kinase–signal transducer and activator of transcription 3 pathway, IL-10 decreased the abundance of the kinases Fyn and Fgr and inhibited the activation of the downstream kinase Syk in mast cells. Together, these findings suggest that an important function of IL-10–producing CD5+ B cells is inhibiting mast cells and IgE-mediated allergic responses.
